Veeva Systems Inc. has recently released its 10-Q report, providing a detailed insight into the company's financial performance and operations. Veeva Systems Inc. offers cloud-based software for the life sciences industry, catering to pharmaceutical and biotechnology companies with a range of solutions including Veeva Commercial Cloud, Veeva Data Cloud, Veeva Development Cloud, Veeva Quality Cloud, and Veeva Business Consulting services.
In the nine months ended October 31, 2025, Veeva derived approximately 47% of its subscription services revenues and 45% of its total revenues from its Commercial Solutions, while 53% of subscription services revenues and 55% of total revenues came from its R&D Solutions. The company's total revenues for the fiscal year ended January 31, 2025, amounted to $2,747 million, representing a 16% year-over-year growth. Moreover, Veeva reported net income of $714 million for the same fiscal year.
As of January 31, 2025, Veeva served 1,477 customers, with 730 Commercial Solutions customers and 1,125 R&D Solutions customers. The company's subscription services revenues are primarily derived from fees from customers accessing its software and data solutions, and for the nine months ended October 31, 2025, subscription services revenues constituted 84% of total revenues.
Veeva's cost of revenues includes expenses related to its computing infrastructure, personnel-related costs, and allocated overhead. The company's operating expenses consist of research and development, sales and marketing, and general and administrative expenses. In addition, Veeva reported other income, net, primarily comprising interest income, amortization of premiums paid or accretion of discounts on investments, and transaction gains or losses on foreign currency, net of hedging costs.
In the three months ended October 31, 2025, Veeva reported revenues of $811,236 thousand, representing an increase from the $699,207 thousand reported for the same period in 2024. The company's gross profit for the same period amounted to $611,771 thousand, reflecting a growth from the $524,818 thousand reported in 2024. Veeva's net income for the three months ended October 31, 2025, was $236,203 thousand, up from the $185,808 thousand reported for the same period in 2024.
Following these announcements, the company's shares moved -9.77%, and are now trading at a price of $244.06. For more information, read the company's full 10-Q submission here.
